Literature DB >> 1359704

NCI-H716 cells as a model for endocrine differentiation in colorectal cancer.

A P de Bruïne1, W N Dinjens, M M Pijls, E P vd Linden, M J Rousch, P T Moerkerk, A F de Goeij, F T Bosman.   

Abstract

In colonic neoplasms, endocrine differentiation is encountered not only in carcinoid tumors but also in adenocarcinomas, where endocrine cells may represent a distinct line of differentiation in the tumor. The significance of endocrine differentiation in colorectal cancer is not well established, partly because of the paucity of tumor cell lines which can serve as a model for studying endocrine differentiation. In this report we describe the properties of NCI-H716 cells, a cell line derived from a poorly differentiated adenocarcinoma of the caecum, under various in vitro conditions and as xenografts in athymic mice. Phenotypical properties were immunohistochemically assessed using a panel of differentiation related antibodies, and also by Northern blot analysis and by electron microscopy. Receptors for biogenic amines and peptide hormones were analyzed by ligand binding assay. These studies show that: 1. NCI-H716 cells can be undifferentiated, or show endocrine, mucin-producing or "amphicrine" properties. 2. Endocrine differentiation of NCI-H716 cells preferentially occurs in xenografts in athymic mice, which suggests that mesenchymal elements induce endocrine differentiation. 3. NCI-H716 cells express large amounts of high affinity receptors for gastrin, serotonin and somatostatin and these substances can regulate growth. Thus, NCI-H716 cells form a suitable model for the study of endocrine differentiation in intestinal epithelium and of auto- or paracrine growth regulation in intestinal neoplasia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359704     DOI: 10.1007/bf02899698

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  14 in total

1.  Fetal and neoplastic expression of the neurotensin gene in the human colon.

Authors:  B M Evers; Z Zhou; V Dohlen; S Rajaraman; J C Thompson; C M Townsend
Journal:  Ann Surg       Date:  1996-05       Impact factor: 12.969

2.  Extracellular matrix components induce endocrine differentiation in vitro in NCI-H716 cells.

Authors:  A P de Bruïne; W N Dinjens; E P van der Linden; M M Pijls; P T Moerkerk; F T Bosman
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

3.  miR-192 is upregulated in T1DM, regulates pancreatic β-cell development and inhibits insulin secretion through suppressing GLP-1 expression.

Authors:  Wen Pan; Yanan Zhang; Chun Zeng; Fen Xu; Jinhua Yan; Jianping Weng
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

Review 4.  Models and Tools for Studying Enteroendocrine Cells.

Authors:  Deborah A Goldspink; Frank Reimann; Fiona M Gribble
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

5.  Activation of enteroendocrine membrane progesterone receptors promotes incretin secretion and improves glucose tolerance in mice.

Authors:  Grace B Flock; Xiemin Cao; Marlena Maziarz; Daniel J Drucker
Journal:  Diabetes       Date:  2012-08-29       Impact factor: 9.461

6.  FGFR2 amplification in colorectal adenocarcinoma.

Authors:  Jamal H Carter; Catherine E Cottrell; Samantha N McNulty; Katinka A Vigh-Conrad; Stephen Lamp; Jonathan W Heusel; Eric J Duncavage
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-11-21

7.  Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: a comparison to native L-cells.

Authors:  Rune Ehrenreich Kuhre; Nicolai Jacob Wewer Albrechtsen; Carolyn Fiona Deacon; Emilie Balk-Møller; Jens Frederik Rehfeld; Frank Reimann; Fiona Mary Gribble; Jens Juul Holst
Journal:  J Mol Endocrinol       Date:  2016-01-27       Impact factor: 5.098

8.  FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival.

Authors:  Anjili Mathur; Christopher Ware; Lenora Davis; Adi Gazdar; Bo-Sheng Pan; Bart Lutterbach
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

9.  Antitumor effect of a neutralizing antibody to vascular endothelial growth factor on liver metastasis of endocrine neoplasm.

Authors:  H Konno; T Arai; T Tanaka; M Baba; K Matsumoto; T Kanai; S Nakamura; S Baba; Y Naito; H Sugimura; A Yukita; M Asano; H Suzuki
Journal:  Jpn J Cancer Res       Date:  1998-09

Review 10.  What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell?

Authors:  Rune E Kuhre; Carolyn F Deacon; Jens J Holst; Natalia Petersen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.